While conventional open-flap surgical interventions provide direct visual access for mechanical debridement and regenerative procedures, they frequently entail significant patient morbidity, extensive soft-tissue trauma, and inevitable post-surgical mucosal recession—a complication of profound concern in aesthetic zones.
Consequently, exploring minimally invasive pathways capable of resolving active dysbiotic lesions while preserving the peri-implant soft-tissue margin has gained paramount clinical interest.
Published as a retrospective case series study, this paper investigates the therapeutic outcomes of treating Peri-implantitis via a flapless surgical access protocol combined with rigorous implant surface decontamination and adjunctive systemic antibiotic therapy.
By bypassing the biological trauma of extensive mucoperiosteal flap elevation, this conservative approach focuses on accessing the contaminated fixture through the sulcular compartment, disrupting virulent subgingival biofilms, and eliminating endotoxins with targeted mechanical/chemical decontamination agents.
The strategic addition of systemic antibiotic coverage works synergistically to eradicate persistent tissue-invasive pathogens, suppress acute immuno-inflammatory cascades, and establish an optimal microenvironment for tissue stabilization.
For periodontists, oral surgeons, and implant clinicians, this study delivers vital clinical insights into the viability, diagnostic indications, and healing dynamics of minimally invasive interventions.
It provides an essential evidence-based reference to refine chairside decision-making, manage patient discomfort, and arrest progressive marginal bone loss without compromising soft-tissue architecture.
📖 Read or Download the Full Publication: Ready to examine the complete surgical methodology, implant surface decontamination protocols, and long-term radiographic outcomes? Click here to read the full article PDF.
